Clinical Trials
🌏 NMPA Page 5NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 49–60 of 75 articles
Soleno Therapeutics Faces Securities Fraud Lawsuit Over Alleged Sham Phase 3 Clinical Trials
China Clinical Trial Regulations: Key Insights on NMPA Reforms 2024
NMPA Foreign Clinical Trial Data: What You Need to Know
Clinical Trial Quality Management Systems: New APAC Standards & Challenges
TrialClinIQ Secures $150K Investment from Caduceus Capital to Transform Clinical Trial Recruitment with AI Technology
Argo Biopharma Doses First Patient in Phase I Trial of siRNA Therapy BW-50218 for TTR-Related Disease
CAR-T Cell Therapy Japan: Regulatory Insights & Clinical Trial Landscape
Sunnybrook Health Sciences Centre Receives $41 Million Investment to Expand Clinical Trials Infrastructure in Canada
CatalYm Doses First Patient in Phase 2/3 Trial of Visugromab for Cancer Cachexia
Spinogenix Launches Phase 2b/3 CLARITY Trial of SPG601 for Fragile X Syndrome Treatment
Samsung Bioepis Begins Phase 1 Trial for Novel ADC SBE303, Expands Sandoz Biosimilar Partnership
Anixa Biosciences Lira-cel CAR-T Therapy Shows Positive Survival Data in Ovarian Cancer Phase 1 Trial